TGF-β plays an important role in the pathogenesis of oral submucous fibrosis (OSMF), of which salivary TGF-β1, β2 and β3 expressions were increased along with increasing clinical grades of OSMF, thereby advancing the stage of the disease. The gene discussed is TGFB1; the disease is oral submucous fibrosis.